Centogene: Difference between revisions

From Research Wiki
← Older edit
Added valuation: Sold operating assets for €8.7M (2025); was Nasdaq-listed
Added founded year: 2006
 
Line 1: Line 1:
{{Company
{{Company
|name=Centogene
|name=Centogene
|founded=2006
|location=Rostock, Germany
|location=Rostock, Germany
|category=Rare Disease / Genomics
|category=Rare Disease / Genomics

Latest revision as of 08:29, 14 April 2026

Template:Company

What They Do[edit]

Rare disease diagnostics and multiomic data platform leveraging AI for genetic insights. Maintains one of the world's largest rare disease datasets.

Funding[edit]

Valuation: Sold operating assets for €8.7M (2025); was Nasdaq-listed Publicly listed (Nasdaq: CNTG)

See Also[edit]

Retrieved from "https://wiki.stamen.health/index.php?title=Centogene&oldid=315"